A regulatory affairs team discovers that a competitor received a Complete Response Letter (CRL) for a similar product due to labeling deficiencies. What is the BEST continuous improvement action?
-
A
Ignore it since it applies to a competitor
-
B
Conduct an internal gap analysis of your own labeling against the cited deficiencies
-
C
Wait for FDA to issue new guidance before acting
-
D
File a citizen petition requesting clarity on labeling requirements